Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Receptor-mediated Endocytosis
Colloids
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Oct 11, 2025

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol
Published on: March 25, 2020
Antonino Puglisi1, Simone Bassini1,2, Erik Reimhult1
1Department of Nanobiotechnology, Institute of Biologically Inspired Materials, University of Natural Resources and Life Sciences (BOKU), Vienna, Austria.
New nanoparticles deliver cyclodextrins (CDs) to target cholesterol buildup in lysosomes. This novel approach offers a promising therapeutic strategy for diseases linked to cholesterol metabolism, overcoming limitations of traditional CD therapies.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: